Prognostic Significance of Uric Acid Levels in Intracerebral Hemorrhage Patients
Wenpei Wu,Zhi Geng,Aimei Wu,Xinyi Chen,Xiaoying Meng,Qianyun Zhang,Zheng Tan,Hong Yue,Juncang Wu
DOI: https://doi.org/10.2147/ndt.s447851
IF: 2.989
2024-03-02
Neuropsychiatric Disease and Treatment
Abstract:Wenpei Wu, 1, 2, &ast Zhi Geng, 3– 5, &ast Aimei Wu, 2, &ast Xinyi Chen, 6, 7 Xiaoying Meng, 2 Qianyun Zhang, 2 Zheng Tan, 2 Hong Yue, 2 Juncang Wu 1, 2 1 Department of Neurology, Hefei Second People's Hospital Affiliated to Bengbu Medical University, Hefei, Anhui, 230011, People's Republic of China; 2 Department of Neurology, Hefei Second People's Hospital, Hefei, Anhui, 230011, People's Republic of China; 3 Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 4 Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei, People's Republic of China; 5 Collaborative Innovation Centre of Neuropsychiatric Disorder and Mental Health, Hefei, 230000, People's Republic of China; 6 Department of Neurology, Hefei Hospital Affiliated to Anhui Medical University (Hefei Second People's Hospital), Hefei, Anhui, 230011, People's Republic of China; 7 The Fifth Clinical School of Medicine, Anhui Medical University, Hefei, Anhui, 230011, People's Republic of China &astThese authors contributed equally to this work Correspondence: Juncang Wu; Hong Yue, Intersection of Guangde Road and Leshui Road, Hefei, Anhui, 230011, People's Republic of China, Tel/Fax +86 551 13956076148 ; +86 551 18949855780, Email ; Background and Purpose: The role of serum uric acid (UA) level in patients suffering from stroke remains controversial. Our aim was to investigate the effect of UA level on clinical outcomes in patients with intracerebral hemorrhage (ICH). Methods: In the retrospective cohort study, we analyzed data from 250 patients with intracerebral hemorrhage (85 women and 165 men) to investigate the difference in UA levels between patients with a good prognosis and those with a poor prognosis. Additionally, we analyzed the impact of UA levels on the risk of short-time prognosis of ICH patients. Results: Patients with a good prognosis presented with significantly lower levels of UA (348.71 ± 84.97 μmol/L) than those with poor prognosis (393.06 ± 148.46 μmol/L). Furthermore, multivariate logistic regression model demonstrated that a high UA level was a likely risk factor for worse prognosis among patients suffering in ICH (odds ratio [95% confidence interval], 1.006 [1.0012, 1.0108]; P = 0.015). Additionally, UA has a threshold effect value of 363.9 μmol/L and was presented in levels that were in a nonlinear relationship with incidence rate of short-time prognosis outcome of ICH patients. Conclusion: Our findings indicate that higher UA levels can increase the risk of poor clinical prognosis in patients with ICH and high UA levels are not conductive to the clinical prognosis of patients with ICH. These findings provide a new perspective on the treatment and prevention of ICH. Keywords: intracerebral hemorrhage, uric acid, oxidative stress, follow-up, nonlinear relationship, prognosis Stroke has become the leading cause of death and disability in China, and in a cross-sectional study of 676,394 participants aged 40 years and older, it was estimated that in 2020, 17.8 (95% CI, 17.5–18.0) million adults in China had experienced a stroke, of whom 3.4 (95% CI, 3.3–3.6) million experienced a first stroke and another 2.3 (95% CI, 2.2–2.4) million died as a result. 1 According to the China Stroke Surveillance Report 2021, ICH accounts for 10.8–4.9% of all stroke events. 2 ICH is the most devastating and difficult-to-treat type of stroke and often leads to severe disability for the survivors. 3 The mechanism of ICH injury includes primary and secondary brain injuries. Primary brain injury is a localized compressive injury to brain tissue caused by the increase in intracranial pressure from the initial cerebral hemorrhage and hematoma enlargement. 4 Secondary brain injury is caused by edema, inflammation, and clotting associated toxicity. 5 The treatment options for hemorrhagic stroke are more limited in comparison to treatments for ischemic strokes. 6 Therefore, secondary prevention of critical damage from cerebral hemorrhage is particularly important, including the management of risk factors, such as hypertension, diabetes and other inducers of metabolic stress. UA is the terminal product of purine metabolism, and it is highly soluble and is excreted by the kidneys. Abnormal UA levels are known to be closely associated with many chronic diseases, such as gout, coronary heart disease and ischemic stroke. 7–9 In addition, it has been demonstrated that elevated UA is -Abstract Truncated-
psychiatry,clinical neurology